AUPH · Aurinia Pharmaceuticals Inc.

$16.08 -0.04 (-0.25%) At close · Sep 4

Russell 2000 member Rebalance outlook locked

Market Cap

$2.14B

133.05M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed	Seller	Relationship	Shares	Market Value	Approx. Sale	Broker
2026-06-05	GREGORY KEENAN	Former Affiliate	9,593	$158,490	2026-06-05	Morgan Stanley Smith Barney LLC Executive Financial Services
2026-06-04	GREGORY KEENAN	Former Affiliate	25,000	$408,435	2026-06-04	Morgan Stanley Smith Barney LLC Executive Financial Services
2026-06-02	GREGORY KEENAN	Officer	25,000	$54,100,000	2026-06-02	Morgan Stanley Smith Barney LLC Executive Financial Services
2026-05-11	PETER GREENLEAF	Former Affiliate	3,136,201	$49,677,424	2026-05-11	Morgan Stanley Smith Barney LLC Executive Financial Services
2026-05-11	JOSEPH MILLER	Former Affiliate	500,503	$7,927,968	2026-05-11	Morgan Stanley Smith Barney LLC Executive Financial Services
2026-05-11	MATTHEW MAXWELL DONLEY	Former Affiliate	717,688	$11,368,178	2026-05-11	Morgan Stanley Smith Barney LLC Executive Financial Services

Showing 1–6 of 6 filings

Key facts CIK 1600620 CUSIP 05156V102 13F (30d) 175 filings 174 filers Visit website Investor relations